Paper32433763
Applications of CRISPR-Cas systems in lactic acid bacteria.
Roberts A and 1 other. FEMS Microbiol Rev, 2020. Cited by 50 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Applications of CRISPR-Cas systems in lactic acid bacteria. Papers, record 32433763. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32433763
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CRISPR-Cas Systems | Major topic |
| Industrial Microbiology | Major topic |
| Lactobacillales | Major topic |
| Microbiota |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42491328 | Exploring the emerging role of CRISPR-Cas systems in probiotic development. | Eng Microbiol | 2026 | https://conductscience.org/library/papers/42491328 | PubMed |
| 42434562 | Advances in gene editing tools for four typical Gram-positive bacteria. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42434562 | PubMed |
| 42182524 | Prospects and challenges in using engineered lactic acid bacteria in aquaculture applications. | Eng Microbiol | 2026 | https://conductscience.org/library/papers/42182524 | PubMed |
| 42075136 | Application and Research Prospects of CRISPR/Cas Gene Editing Technology in Lactic Acid Bacteria. | Microorganisms | 2026 | https://conductscience.org/library/papers/42075136 | PubMed |
| 41843109 | Beyond new pills: integrative strategies to overcome multidrug-resistant bacteria. | Arch Microbiol | 2026 | https://conductscience.org/library/papers/41843109 | PubMed |
| 41524418 | Enhanced editing of Bifidobacterium lactis using the endogenous Type I-G CRISPR-Cas system. | Appl Environ Microbiol | 2026 | https://conductscience.org/library/papers/41524418 | PubMed |
| 41517189 | Genetic Engineering and Encapsulation Strategies for Lacticaseibacillus rhamnosus Enhanced Functionalities and Delivery: Recent Advances and Future Approaches. | Foods | 2026 | https://conductscience.org/library/papers/41517189 | PubMed |
| 41489362 | Occurrence and applications of CRISPR-Cas systems in bifidobacteria. | Appl Environ Microbiol | 2026 | https://conductscience.org/library/papers/41489362 | PubMed |
| 41415685 | Recent advances of engineered probiotics for therapeutic applications. | Biodes Res | 2025 | https://conductscience.org/library/papers/41415685 | PubMed |
| 41182907 | A comprehensive review of genomic-scale genetic engineering as a strategy to improve bacterial productivity. | Microbiology (Reading) | 2025 | https://conductscience.org/library/papers/41182907 | PubMed |
| 41032193 | Pangenome Analysis and Genome-Guided Probiotic Evaluation of Cyclic Dipeptides Producing Levilactobacillus brevis DY55bre Strain from a Lactic Acid Fermented Shalgam to Assess Its Metabolic, Probiotic Potentials, and Cytotoxic Effects on Colorectal Cancer Cells. | Probiotics Antimicrob Proteins | 2026 | https://conductscience.org/library/papers/41032193 | PubMed |
| 40949776 | CRISPR-FMC: a dual-branch hybrid network for predicting CRISPR-Cas9 on-target activity. | Front Genome Ed | 2025 | https://conductscience.org/library/papers/40949776 | PubMed |
| 40774991 | Comprehensive in vitro and whole-genome characterization of probiotic properties in Pediococcus acidilactici P10 isolated from Iranian broiler chicken. | Sci Rep | 2025 | https://conductscience.org/library/papers/40774991 | PubMed |
| 40530826 | Being a better version of yourself: genetically engineered probiotic bacteria as host defense enhancers in the control of intestinal pathogens. | Gut Microbes | 2025 | https://conductscience.org/library/papers/40530826 | PubMed |
| 40284709 | Safety Assessment of Lactiplantibacillus plantarum GUANKE Based on Whole-Genome Sequencing, Phenotypic, and Anti-Inflammatory Capacity Analysis. | Microorganisms | 2025 | https://conductscience.org/library/papers/40284709 | PubMed |
| 39377977 | Exploring the Probiotic Potential of Bacteroides spp. Within One Health Paradigm. | Probiotics Antimicrob Proteins | 2025 | https://conductscience.org/library/papers/39377977 | PubMed |
| 38990000 | Characterization of Ligilactobacillus salivarius CRISPR-Cas systems. | mSphere | 2024 | https://conductscience.org/library/papers/38990000 | PubMed |
| 38253975 | Assessment of safety and in situ antibacterial activity of Weissella cibaria strains isolated from dairy farms in Minas Gerais State, Brazil, for their food application. | Braz J Microbiol | 2024 | https://conductscience.org/library/papers/38253975 | PubMed |
| 37998819 | The Importance of a Healthy Microbiome in Pregnancy and Infancy and Microbiota Treatment to Reverse Dysbiosis for Improved Health. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/37998819 | PubMed |
| 37969339 | Complete genome sequence of Pediococcus acidilactici CACC 537 isolated from canine. | J Anim Sci Technol | 2023 | https://conductscience.org/library/papers/37969339 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32433763
GET https://conductscience.org/api/papers/v1/32433763/cited_by?page=2